Shao Yang David Zhang, in Bettendorf, IA - Dentist

Shao Yang David Zhang, is a Dentist based in Bettendorf, Iowa. Shao Yang David Zhang is licensed to practice in Iowa (license number DDS-10097) and his current practice location is 3520 Utica Ridge Rd, Bettendorf, Iowa. He can be reached at his office (for appointments etc.) via phone at (563) 359-9165.

NPI number for Shao Yang David Zhang is 1053003178 and his current mailing address is 3520 Utica Ridge Rd, Bettendorf, Iowa. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1053003178.

Contact Information

	Shao Yang David Zhang,
	3520 Utica Ridge Rd, Bettendorf, IA 52722-1620
	(563) 359-9165
	Not Available

Healthcare Provider's Profile

Full Name	Shao Yang David Zhang
Gender	Male
Speciality	Dentist
Location	3520 Utica Ridge Rd, Bettendorf, Iowa
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1053003178
Provider Enumeration Date: 05/25/2023
Last Update Date: 06/26/2023

Medical Identifiers

Medical identifiers for Shao Yang David Zhang such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053003178	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
122300000X	Dentist	DDS-10097 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shao Yang David Zhang is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Shao Yang David Zhang, 3520 Utica Ridge Rd, Bettendorf, IA 52722-1620 Ph: (563) 359-9165	Shao Yang David Zhang, 3520 Utica Ridge Rd, Bettendorf, IA 52722-1620 Ph: (563) 359-9165

News Archive

Bristol-Myers Squibb, Pfizer and Portola partner to conduct clinical study of PRT4445 and ELIQUIS

Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company and Pfizer Inc. today announced a clinical collaboration agreement to conduct a proof-of-concept study of PRT4445 and the investigational oral Factor Xa inhibitor ELIQUIS (apixaban).

Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

Stellaris Health Network announces expiry of contract with Empire Blue Cross Blue Shield

Stellaris Health Network said today that its contract with Empire Blue Cross Blue Shield expired at midnight March 31st ending a long-standing relationship with the prominent health insurance provider that is owned by WellPoint Inc., one of the nation's largest health insurance conglomerates. The expiration follows several months of unsuccessful efforts to reach a new agreement giving the hospitals reimbursement rates that are consistent with those being paid by other health insurers in the market.

Significant opportunity for alternative ulcerative colitis biological therapy

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a biological therapy with a mechanism of action other than tumor necrosis factor alpha (TNF-alpha) inhibition for the treatment of moderate to severe ulcerative colitis, would earn a 25 percent patient share according to surveyed U.S. gastroenterologists. Similarly, in Europe, such an agent would also earn 25 percent patient share according to surveyed European gastroenterologists.

Study reveals racial, ethnic disparities in mortality rates for common conditions among VA patients

A study of Veterans hospitalized for common conditions in the Veterans Affairs (VA) healthcare system confirms that adjusted mortality rates are lower for Black compared to White Veterans – while also showing higher adjusted mortality rates among Hispanic Veterans relative to White Veterans across most risk-adjustment models, reports the December issue of Medical Care.

Dentist in Bettendorf, IA

Dr. Jason R Benoit, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3024 Victoria St, Bettendorf, IA 52722 Phone: 563-332-2447 Fax: 563-332-9787
Dr. Miranda Foster, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2515 Maplecrest Rd, Bettendorf, IA 52722 Phone: 563-332-1600
Joel W Teagarden, DDS Dentist Medicare: Medicare Enrolled Practice Location: 3520 Utica Ridge Rd, Bettendorf, IA 52722 Phone: 563-359-9165 Fax: 563-359-1824
Dr. Michael Wayne Vandello, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5532 Joshua St, Bettendorf, IA 52722 Phone: 563-320-3348
Dr. David Rex Schleusener, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1980 Spruce Hills Dr, Bettendorf, IA 52722 Phone: 563-359-3533
Dr. Thomas Paul Irwin Jr., DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 3024 Victoria St, Bettendorf, IA 52722 Phone: 563-332-2447 Fax: 563-332-9787

Shao Yang David Zhang, - Dentist in Bettendorf, IA